Evidence map›Paper›PMID 8451190›Full record

ArticleNucleic acids research1993

Functional analysis of a C. elegans trans-splice acceptor.

R Conrad, R F Liou, T Blumenthal

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Genome research · 2017
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

R ConradDepartment of Biology, Indiana University, Bloomington 47405.
R F Liou
T Blumenthal
Indiana University Bloomington · US

Funding

TRANS-SPLICING IN C ELEGANSR01GM042432 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BLUMENTHAL, THOMAS · 1992 to 2011
$3.9M
Trans-splicing in C. ElegansR56GM042432 · NIGMS · UNIVERSITY OF COLORADO · PI BLUMENTHAL, THOMAS · 2007 to 2007
$360k
REGULATION OF C ELEGANS VITELLOGENIN GENESR01GM030870 · NIGMS · INDIANA UNIVERSITY BLOOMINGTON · PI BLUMENTHAL, THOMAS · 1985 to 1995
–
NIGMS NIH HHS GM30870NIGMS NIH HHS GM42432
6 · The paper itself

Abstract

The rol-6 gene is trans-spliced to the 22 nt leader, SL1, 173 nt downstream of the transcription start. We have analyzed splicing in transformants carrying extrachromosomal arrays of rol-6 with mutations in the trans-splice acceptor site. This site is a close match to the consensus, UUUCAG, that is highly conserved in both trans-splice and intron acceptor sites in C. elegans. When the trans-splice site was inactivated by mutating the perfectly-conserved AG, trans-splicing still occurred, but at a cryptic site 20 nt upstream. We tested the frequency with which splicing switched from the normal site to the cryptic site when the pyrimidines at this site were changed to A's. Since most C. elegans 3' splice sites lack an obvious polypyrimidine tract, we hypothesized that these four pyrimidines might play this role, and indeed mutation of these bases caused splicing to switch to the cryptic site. We also demonstrated that a major reason the downstream site is normally favored is because it occurs at a boundary between A+U rich and non-A+U rich RNA. When the RNA between the two splice sites was made less A+U rich, splicing occurred preferentially at the upstream site.

Indexed as

Amino Acid SequenceAnimalsBase SequenceCaenorhabditis elegansCollagenConsensus SequenceIntronsMolecular Sequence DataRNA SplicingCollagen

Identifiers

PMID8451190
PMCPMC309224
OpenAlexW1997267580

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.